• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌病中的氧化磷酸化缺陷与线粒体DNA突变

OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy.

作者信息

Zeviani M, Mariotti C, Antozzi C, Fratta G M, Rustin P, Prelle A

机构信息

Istituto Nazionale Neurologico Carlo Besta, Milano, Italy.

出版信息

Muscle Nerve Suppl. 1995;3:S170-4. doi: 10.1002/mus.880181433.

DOI:10.1002/mus.880181433
PMID:7603520
Abstract

Defects of the mitochondrial respiratory chain in cardiac muscle are an important, yet still overlooked cause of heart failure. In 16 of 32 endocardial biopsies from infants affected by "idiopathic" hypertrophic cardiomyopathy we demonstrated a remarkable decrease of activity of either complex I, or complex IV, or both, relative to complex II + III activity which was taken as an index of mitochondrial proliferation. At the molecular level, several mtDNA mutations have been associated with cardiomyopathy. For instance, MIMyCa is a maternally inherited syndrome presenting with a variable combination of skeletal and heart muscle failure associated with a heteroplasmic A3260G transition in the tRNALeu(UUR) gene. To study the effects of the mutation in a controlled system, we prepared clones of transmitochondrial cybrids by fusing mutant cytoplasts with mtDNA-less tumor cells. Two groups of clones were identified: nearly 100% mutant (M group) and nearly 100% wild-type (WT group). The means of complex I and IV in the M group were 63% and 67% relative to the WT group. The O2 consumption in the M group was 36%, and the lactate production was 218% of that in the WT group. MtDNA-specific translation was defective in M clones. The study of transmitochondrial cybrids is an important clue to test the pathogenicity of mtDNA mutations.

摘要

心肌线粒体呼吸链缺陷是心力衰竭的一个重要但仍被忽视的原因。在32例受“特发性”肥厚型心肌病影响的婴儿的心内膜活检样本中,有16例显示相对于作为线粒体增殖指标的复合物II + III活性,复合物I或复合物IV或两者的活性显著降低。在分子水平上,几种线粒体DNA(mtDNA)突变与心肌病有关。例如,MIMyCa是一种母系遗传综合征,表现为骨骼肌和心肌功能衰竭的不同组合,与tRNALeu(UUR)基因中的异质性A3260G转换有关。为了在可控系统中研究该突变的影响,我们通过将突变细胞质体与无mtDNA的肿瘤细胞融合制备了线粒体杂交细胞克隆。鉴定出两组克隆:近100%突变型(M组)和近100%野生型(WT组)。M组中复合物I和IV的平均值相对于WT组分别为63%和67%。M组的氧气消耗量为WT组的36%,乳酸产量为WT组的218%。M克隆中的mtDNA特异性翻译存在缺陷。线粒体杂交细胞的研究是测试mtDNA突变致病性的重要线索。

相似文献

1
OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy.心肌病中的氧化磷酸化缺陷与线粒体DNA突变
Muscle Nerve Suppl. 1995;3:S170-4. doi: 10.1002/mus.880181433.
2
Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNA(Leu(UUR)) mutation associated with maternally inherited myopathy and cardiomyopathy.携带与母系遗传的肌病和心肌病相关的tRNA(Leu(UUR))突变的转化体胞质杂种的呼吸能力缺陷和线粒体蛋白质合成异常。
J Clin Invest. 1994 Mar;93(3):1102-7. doi: 10.1172/JCI117061.
3
Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation.线粒体医学——氧化磷酸化缺陷的分子病理学
Ann Clin Lab Sci. 2001 Jan;31(1):25-67.
4
Functional and molecular mitochondrial abnormalities associated with a C --> T transition at position 3256 of the human mitochondrial genome. The effects of a pathogenic mitochondrial tRNA point mutation in organelle translation and RNA processing.与人类线粒体基因组第3256位C→T转换相关的功能性和分子性线粒体异常。致病性线粒体tRNA点突变在细胞器翻译和RNA加工中的作用。
J Biol Chem. 1996 Jan 26;271(4):2347-52. doi: 10.1074/jbc.271.4.2347.
5
The emerging concept of mitochondrial cardiomyopathies.线粒体心肌病的新兴概念。
Am Heart J. 2001 Jan;141(1):E1. doi: 10.1067/mhj.2001.112088.
6
Fatal mitochondrial myopathy, lactic acidosis, and complex I deficiency associated with a heteroplasmic A --> G mutation at position 3251 in the mitochondrial tRNALeu(UUR) gne.致命性线粒体肌病、乳酸性酸中毒及与线粒体tRNALeu(UUR)基因第3251位A→G异质性突变相关的复合体I缺乏症
Hum Genet. 1996 Mar;97(3):269-73. doi: 10.1007/BF02185750.
7
Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.线粒体DNA编码的tRNA基因缺陷患者骨骼肌中氧化磷酸化复合物的免疫组织化学分析。
J Clin Pathol. 2009 Feb;62(2):172-6. doi: 10.1136/jcp.2008.061267.
8
Identification and biochemical characterization of the novel mutation m.8839G>C in the mitochondrial ATP6 gene associated with NARP syndrome.与NARP综合征相关的线粒体ATP6基因新型突变m.8839G>C的鉴定及生化特征分析
Genes Brain Behav. 2013 Nov;12(8):812-20. doi: 10.1111/gbb.12089. Epub 2013 Oct 25.
9
Mitochondrial cardiomyopathy: molecular and biochemical analysis.线粒体心肌病:分子与生化分析
Pediatr Cardiol. 1997 Jul-Aug;18(4):251-60. doi: 10.1007/s002469900169.
10
Mitochondrial defects in cardiomyopathy and neuromuscular disease.心肌病和神经肌肉疾病中的线粒体缺陷。
Am Heart J. 2000 Feb;139(2 Pt 3):S70-85. doi: 10.1067/mhj.2000.103934.

引用本文的文献

1
Transcriptomic signals of mitochondrial dysfunction and OXPHOS dynamics in fast-growth chicken.快速生长鸡中线粒体功能障碍和 OXPHOS 动态的转录组信号
PeerJ. 2022 May 4;10:e13364. doi: 10.7717/peerj.13364. eCollection 2022.
2
INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.用于模拟肥厚型心肌病能量改变的诱导多能干细胞
Cond Med. 2019;2(4):142-151.
3
Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
用于模拟代谢紊乱和心肌病中生物能量障碍的人诱导多能干细胞。
Cardiovasc Res. 2021 Feb 22;117(3):694-711. doi: 10.1093/cvr/cvaa125.
4
Clinical presentations of mitochondrial cardiomyopathies.线粒体心肌病的临床表现。
Pediatr Cardiol. 2004 Sep-Oct;25(5):443-50. doi: 10.1007/s00246-003-0490-7. Epub 2004 Jun 8.
5
Electron transport chain defects in heart failure.心力衰竭中的电子传递链缺陷。
Heart Fail Rev. 2002 Apr;7(2):131-9. doi: 10.1023/a:1015372407647.
6
Clinical mitochondrial genetics.临床线粒体遗传学
J Med Genet. 1999 Jun;36(6):425-36.
7
Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy.肥厚型心肌病患儿的心脏线粒体功能障碍与DNA耗竭
J Inherit Metab Dis. 1997 Sep;20(5):674-80. doi: 10.1023/a:1005322409330.
8
On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders.关于泽尔韦格综合征及其他过氧化物酶体疾病中花生四烯酸(20:4n-6)、二十二碳五烯酸(22:5n-6)和二十二碳六烯酸(22:6n-3)减少的分子病因学。
Mol Cell Biochem. 1997 Mar;168(1-2):101-15. doi: 10.1023/a:1006895209833.